Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Ideaya Biosciences Inc (NASDAQ: IDYA) closed at $21.38 in the last session, down -4.64% from day before closing price of $22.42. In other words, the price has decreased by -$4.64 from its previous closing price. On the day, 0.72 million shares were traded. IDYA stock price reached its highest trading level at $22.27 during the session, while it also had its lowest trading level at $21.1.
Ratios:
We take a closer look at IDYA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 22.93 and its Current Ratio is at 22.93. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 18, 2024, initiated with a Overweight rating and assigned the stock a target price of $51.
On November 05, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $27.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $50.UBS initiated its Buy rating on October 24, 2024, with a $50 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.
WHITE MICHAEL ANTHONY sold 28,500 shares of IDYA for $1,032,884 on May 29 ’24. The Chief Scientific Officer now owns 0 shares after completing the transaction at $36.24 per share. On May 15 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 83,856 shares for $42.90 each. As a result, the insider received 3,597,756 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 1847911808 and an Enterprise Value of 946678848. For the stock, the TTM Price-to-Sale (P/S) ratio is 471.41 while its Price-to-Book (P/B) ratio in mrq is 1.56. Its current Enterprise Value per Revenue stands at 241.377 whereas that against EBITDA is -4.258.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.73, which has changed by -0.51867753 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $47.74, while it has fallen to a 52-week low of $22.10. The 50-Day Moving Average of the stock is -14.27%, while the 200-Day Moving Average is calculated to be -35.59%.
Shares Statistics:
According to the various share statistics, IDYA traded on average about 931.47K shares per day over the past 3-months and 811280 shares per day over the past 10 days. A total of 86.36M shares are outstanding, with a floating share count of 77.40M. Insiders hold about 10.45% of the company’s shares, while institutions hold 100.83% stake in the company. Shares short for IDYA as of 1738281600 were 9582473 with a Short Ratio of 10.38, compared to 1735603200 on 9999282. Therefore, it implies a Short% of Shares Outstanding of 9582473 and a Short% of Float of 12.36.
Earnings Estimates
A detailed examination of Ideaya Biosciences Inc (IDYA) is currently in progress, with 11.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.64, with high estimates of -$0.46 and low estimates of -$0.84.
Analysts are recommending an EPS of between -$1.58 and -$2.72 for the fiscal current year, implying an average EPS of -$2.4. EPS for the following year is -$2.7, with 11.0 analysts recommending between -$2.11 and -$3.49.
